HIGH-THROUGHPUT SCREEN OF ADVANCED PROSTATE CANCER ORGANOIDS AND PDX PRECLINICAL TRIALS TO IDENTIFY SINGLE AND COMBINATION THERAPIES CORRELATED WITH

The Geneva Foundation

Investigators